{"id":"https://openalex.org/W51813618","doi":null,"title":"Biological activity of the multitargeted antifolate, MTA (LY231514), in human cell lines with different resistance mechanisms to antifolate drugs.","display_name":"Biological activity of the multitargeted antifolate, MTA (LY231514), in human cell lines with different resistance mechanisms to antifolate drugs.","alternate_titles":[],"publication_year":1999,"publication_date":"1999-04-01","ids":{"openalex":"https://openalex.org/W51813618","mag":"51813618","pmid":"https://pubmed.ncbi.nlm.nih.gov/10598558"},"language":"en","primary_location":{"id":"pmid:10598558","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10598558","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in oncology","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W51813618"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5114246911","display_name":"Richard M. Schultz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R M Schultz","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113888762","display_name":"Chen Vj","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"V J Chen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067360483","display_name":"Jesse R. Bewley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J R Bewley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109547292","display_name":"E F Roberts","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E F Roberts","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"C Shih","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C Shih","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5011807063","display_name":"Jo Ann Dempsey","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J A Dempsey","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.0839,"has_fulltext":false,"cited_by_count":97,"citation_normalized_percentile":{"value":0.8624779,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"26","issue":"2 Suppl 6","first_page":"68","last_page":"73"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.5083000063896179,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.5083000063896179,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10499","display_name":"Folate and B Vitamins Research","score":0.17260000109672546,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.06300000101327896,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mta","display_name":"MTA","score":0.7070000171661377},{"id":"https://openalex.org/keywords/pemetrexed","display_name":"pemetrexed","score":0.9879999756813049},{"id":"https://openalex.org/keywords/antifolate-resistance","display_name":"antifolate resistance","score":0.8090000152587891},{"id":"https://openalex.org/keywords/thymidylate-synthase","display_name":"thymidylate synthase","score":0.8370000123977661},{"id":"https://openalex.org/keywords/dihydrofolate-reductase","display_name":"dihydrofolate reductase","score":0.9660000205039978},{"id":"https://openalex.org/keywords/glycinamide-ribonucleotide-formyltransferase","display_name":"glycinamide ribonucleotide formyltransferase","score":0.9670000076293945},{"id":"https://openalex.org/keywords/raltitrexed","display_name":"raltitrexed","score":0.7250000238418579},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.8759999871253967},{"id":"https://openalex.org/keywords/thymidine","display_name":"thymidine","score":0.6700000166893005},{"id":"https://openalex.org/keywords/hypoxanthine","display_name":"hypoxanthine","score":0.9629999995231628},{"id":"https://openalex.org/keywords/thymidine-phosphorylase","display_name":"thymidine phosphorylase","score":0.621999979019165},{"id":"https://openalex.org/keywords/thymidine-kinase","display_name":"thymidine kinase","score":0.6869999766349792}],"concepts":[{"id":"https://openalex.org/C123321153","wikidata":"https://www.wikidata.org/wiki/Q22676802","display_name":"Thymidylate synthase","level":4,"score":0.8561113476753235},{"id":"https://openalex.org/C2781382166","wikidata":"https://www.wikidata.org/wiki/Q50573407","display_name":"Antifolate","level":4,"score":0.8379709720611572},{"id":"https://openalex.org/C2781116151","wikidata":"https://www.wikidata.org/wiki/Q410305","display_name":"Hypoxanthine","level":3,"score":0.8061800003051758},{"id":"https://openalex.org/C2781320022","wikidata":"https://www.wikidata.org/wiki/Q417149","display_name":"Dihydrofolate reductase","level":3,"score":0.7159590125083923},{"id":"https://openalex.org/C2777108182","wikidata":"https://www.wikidata.org/wiki/Q422464","display_name":"Thymidine","level":3,"score":0.6522671580314636},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5819001793861389},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.5250375270843506},{"id":"https://openalex.org/C2779268555","wikidata":"https://www.wikidata.org/wiki/Q15304877","display_name":"Raltitrexed","level":5,"score":0.5213690400123596},{"id":"https://openalex.org/C2778397455","wikidata":"https://www.wikidata.org/wiki/Q50429865","display_name":"Antimetabolite","level":3,"score":0.519318699836731},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.483605295419693},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.4616694748401642},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3942863941192627},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3941515386104584},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.383442223072052},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37245795130729675},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.23703637719154358},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.21134081482887268},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2106427550315857},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.186781108379364},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.08696037530899048},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068437","descriptor_name":"Pemetrexed","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001692","descriptor_name":"Biological Transport","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005493","descriptor_name":"Folic Acid Antagonists","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005493","descriptor_name":"Folic Acid Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005971","descriptor_name":"Glutamates","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005971","descriptor_name":"Glutamates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006147","descriptor_name":"Guanine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D006147","descriptor_name":"Guanine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006147","descriptor_name":"Guanine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013940","descriptor_name":"Thymidylate Synthase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:10598558","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10598558","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in oncology","raw_type":"Journal Article"},{"id":"mag:51813618","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10598558","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2284934451","https://openalex.org/W24018398","https://openalex.org/W1979012566","https://openalex.org/W1977167317","https://openalex.org/W2027463875","https://openalex.org/W259072379","https://openalex.org/W1988007280","https://openalex.org/W2993550752","https://openalex.org/W2075672934","https://openalex.org/W2569405395"],"abstract_inverted_index":{"Prior":[0],"studies":[1,298],"have":[2,41],"indicated":[3],"that":[4,14,300],"MTA":[5,49,75,129,249,286,313],"requires":[6],"intracellular":[7],"polyglutamation":[8],"for":[9,46,61,86,91,97,119,179,196,260],"optimal":[10],"cytotoxic":[11,246],"effect":[12],"and":[13,31,95,121,142,153,194,198,205,230,236,254,264,290],"these":[15],"polyglutamates":[16],"potently":[17],"inhibit":[18],"several":[19,51],"key":[20],"enzymes":[21],"of":[22,74,82,128,148,192,209,222,238,248,312],"folate":[23],"metabolism,":[24],"including":[25],"thymidylate":[26],"synthase":[27],"(TS),":[28],"dihydrofolate":[29,183],"reductase,":[30],"glycinamide":[32],"ribonucleotide":[33],"formyltransferase":[34],"(GARFT).":[35],"In":[36,155],"the":[37,43,64,72,122,146,164,190,245,310],"present":[38],"studies,":[39],"we":[40],"investigated":[42],"mechanistic":[44],"basis":[45],"resistance":[47,62,83,116,202,261,284],"to":[48,67,102,112,262,285,303],"in":[50,71,130,163,227,250,301],"human":[52],"tumor":[53],"cell":[54,57],"lines.":[55,166],"The":[56,80,106,126,167],"lines":[58,107],"were":[59,233],"developed":[60],"by":[63,137,177,189,271,295],"gradual":[65],"exposure":[66],"stepwise":[68],"(fivefold)":[69],"increases":[70],"concentration":[73],"over":[76],"a":[77,171,182],"5-month":[78],"period.":[79],"degree":[81],"was":[84,117,133,203,293],"140-fold":[85],"GC3":[87],"colon":[88,256],"carcinoma,":[89,94],"117-fold":[90],"HCT-8":[92],"ileocecal":[93],"729-fold":[96],"CCRF-CEM":[98],"leukemia":[99],"cells":[100,132,168,214,232,258,278],"adapted":[101],"2":[103],"micromol/L":[104],"MTA.":[105],"had":[108],"strong":[109],"cross-resistance":[110],"(>3,200-fold)":[111],"raltitrexed.":[113],"Only":[114,212],"modest":[115],"noted":[118],"methotrexate":[120],"GARFT":[123],"inhibitor,":[124],"LY309887.":[125],"cytotoxicity":[127,292],"wild-type":[131,239],"only":[134],"partially":[135],"alleviated":[136],"thymidine":[138,157],"addition":[139,147,302],"(5":[140],"micromol/L)":[141,152],"complete":[143],"protection":[144,176,188],"required":[145],"both":[149],"hypoxanthine":[150,193],"(100":[151],"thymidine.":[154],"contrast,":[156],"alone":[158],"totally":[159],"lacked":[160],"protective":[161],"activity":[162,218,247],"MTA-resistant":[165],"either":[169],"demonstrated":[170,279],"GARFT-like":[172],"reversal":[173,185],"pattern":[174,186],"(complete":[175,187],"hypoxanthine)":[178],"GC3MTA":[180,213,231],"or":[181],"reductase-like":[184],"combination":[191],"thymidine)":[195],"HCT-8MTA":[197],"CCRF-CEM(MTA)":[199],"cells.":[200],"Cellular":[201],"multifactorial":[204],"stable":[206],"on":[207],"removal":[208],"selective":[210],"pressure.":[211],"showed":[215],"increased":[216],"TS":[217,268,304],"(approximately":[219],"40-fold).":[220],"Accumulations":[221],"3H-MTA":[223],"at":[224],"24":[225],"hours":[226],"CCRF-CEM(MTA),":[228],"HCT-8MTA,":[229],"2%,":[234],"6%,":[235],"46%":[237],"values,":[240],"respectively.":[241],"We":[242],"also":[243],"evaluated":[244],"MCF-7":[251],"breast":[252],"carcinoma":[253,257],"H630":[255],"selected":[259],"raltitrexed":[263,289],"5-fluorouracil,":[265],"respectively,":[266],"via":[267],"amplification":[269],"(provided":[270],"Dr":[272],"P.G.":[273],"Johnston,":[274],"Belfast,":[275],"Ireland).":[276],"These":[277,297],"more":[280],"than":[281],"200-fold":[282],"less":[283],"compared":[287],"with":[288],"MTA-induced":[291],"prevented":[294],"hypoxanthine.":[296],"suggest":[299],"modulation,":[305],"secondary":[306],"targets":[307],"emerge":[308],"during":[309],"development":[311],"resistance.":[314]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W51813618","counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
